Steve Ubl built PhRMA into a more aggressive operation, one that has tangled with President Donald Trump as he seeks to curb ...

After shedding expensive commercial infrastructure and pivoting to a partnership model, the company is now positioning its ...

For the past year, the pharmaceutical industry has wrestled with Washington, as President Donald Trump has demanded that drug ...

As foundational AI models muscle into biosciences and pharmaceuticals, what does it mean for India's $55-billion ...

The COVAX programme has signed deals for hundreds of millions of doses to vaccinate people in poor and lower-middle income ...

Many CHROs I work with are brilliant, deeply empathetic, and genuinely trying to navigate an impossible set of demands. The problem is that the role itself in terms of its scope, its positioning, its ...

Moderna CEO Stéphane Bancel’s total compensation remained remarkably stable last year at $19.9 million, even as the vaccines company navigated a “challenging regulatory and business environment.” ...

That raises the stakes for a second area of Moderna’s research. In a partnership with Merck, it’s been using its mRNA ...

McCormick CEO Brendan Foley joins 'Squawk on the Street' to discuss the company's deal with Unilever, how investors should ...

Nvidia CEO Jensen Huang and Marvell Technology CEO Matt Murphy discuss Nvidia's $2 billion investment in Marvell, the ...

The Food and Drug Administration last week refused to review Moderna’s application for its messenger RNA flu vaccine, in a move that the Cambridge biotech said came as a surprise. In a “Refusal to ...